His primary areas of study are Epilepsy, Adverse effect, Anesthesia, Drug and Transcranial magnetic stimulation. His Epilepsy research integrates issues from Discontinuation, Surgery, Adjunctive treatment, Electroencephalography and Pediatrics. He interconnects Drug withdrawal, Randomized controlled trial and Seizure control in the investigation of issues within Adverse effect.
He combines subjects such as Drug Resistant Epilepsy, Placebo, Tolerability and Internal medicine with his study of Anesthesia. His Transcranial magnetic stimulation research incorporates elements of Motor cortex and Inhibitory postsynaptic potential. His Pharmacology study combines topics in areas such as Anticonvulsant and Oxcarbazepine.
Gaetano Zaccara mostly deals with Epilepsy, Neuroscience, Internal medicine, Anesthesia and Transcranial magnetic stimulation. His studies deal with areas such as Tolerability, Adverse effect, Pharmacology, Placebo and Pediatrics as well as Epilepsy. His work deals with themes such as Anticonvulsant and Carbamazepine, Oxcarbazepine, which intersect with Pharmacology.
In general Internal medicine, his work in Meta-analysis is often linked to In patient linking many areas of study. Gaetano Zaccara works mostly in the field of Anesthesia, limiting it down to topics relating to Phenytoin and, in certain cases, Phenobarbital. As part of the same scientific family, Gaetano Zaccara usually focuses on Transcranial magnetic stimulation, concentrating on Motor cortex and intersecting with Neuroimaging.
The scientist’s investigation covers issues in Epilepsy, Internal medicine, Adverse effect, Lacosamide and Carbamazepine. His biological study spans a wide range of topics, including Neurology, Pediatrics and Drug. His Internal medicine research includes elements of Drug Resistant Epilepsy and Placebo.
His Adverse effect research is multidisciplinary, incorporating perspectives in Clinical trial, Adjunctive treatment and Pill. His Lacosamide research focuses on Pharmacology and how it relates to Brivaracetam, Oxcarbazepine, Anticonvulsant and Diltiazem. His research in Carbamazepine intersects with topics in Tolerability, Zonisamide and Phenobarbital.
Epilepsy, Internal medicine, Placebo, Relative risk and Dravet syndrome are his primary areas of study. He has researched Epilepsy in several fields, including Observational study, Cochrane Library and Pediatrics. Gaetano Zaccara works mostly in the field of Internal medicine, limiting it down to topics relating to Lacosamide and, in certain cases, Status epilepticus, as a part of the same area of interest.
His Placebo research is multidisciplinary, incorporating elements of Efficacy, Randomization, Adjunctive treatment and Atonic seizure. His Eslicarbazepine acetate research is multidisciplinary, relying on both Discontinuation and Zonisamide. His studies in Levetiracetam integrate themes in fields like Anesthesia, Propofol, Lorazepam, Midazolam and Phenytoin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Idiosyncratic adverse reactions to antiepileptic drugs.
Gaetano Zaccara;Diego Franciotta;Emilio Perucca.
Epilepsia (2007)
Seizure control and treatment in pregnancy: Observations from the EURAP epilepsy pregnancy registry
Torbjörn Tomson;D. Battino;E. Bonizzoni;J. Craig.
Neurology (2006)
Incidence and predictors of acute symptomatic seizures after stroke
E. Beghi;R. D'Alessandro;S. Beretta;D. Consoli.
Neurology (2011)
Clinical Pharmacokinetics of Valproic Acid — 1988
Gaetano Zaccara;Andrea Messori;Flavio Moroni.
Clinical Pharmacokinectics (1988)
Transcranial magnetic stimulation and epilepsy
Carlo Alberto Tassinari;Massimo Cincotta;Gaetano Zaccara;Roberto Michelucci.
Clinical Neurophysiology (2003)
The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trials
Gaetano Zaccara;Pierfranco Gangemi;Piero Perucca;Luigi Specchio.
Epilepsia (2011)
Slow repetitive TMS for drug-resistant epilepsy: Clinical and EEG findings of a placebo-controlled trial
Roberto Cantello;Simone Rossi;Claudia Varrasi;Monica Ulivelli.
Epilepsia (2007)
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs.
Gaetano Zaccara;Emilio Perucca.
Epileptic Disorders (2014)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi;Francesco Brigo;Eugen Trinka;Gaetano Zaccara.
Drugs (2018)
Modulation of interhemispheric inhibition by volitional motor activity: an ipsilateral silent period study
Fabio Giovannelli;Alessandra Borgheresi;Fabrizio Balestrieri;Gaetano Zaccara.
The Journal of Physiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tübingen
University of Bologna
University of Siena
University of Pavia
University of Verona
Mario Negri Institute for Pharmacological Research
Istituto Neurologico Carlo Besta
Albert Einstein College of Medicine
University of Genoa
Paracelsus Medical University
Flinders University
University of Michigan–Ann Arbor
The University of Texas at Austin
University of Hong Kong
Habley Medical Technology Corporation
Grenoble Alpes University
University of Queensland
Shandong University
Technical University of Denmark
University Health Network
Environment Agency
University of Manitoba
University of Padua
University of Turin
National Institutes of Health
Johns Hopkins University School of Medicine